Industry experts gather to explore oligonucleotide innovation, delivery strategies, and commercialization pathways BEIJING, July 29, 2025 /PRNewswire/ -- Tsingke Biotech, a leading provider ...

Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully hosted the 2025 Small Nucleic Acid Therapeutics Roundtable on July 26 in Beijing. The event convened ...

With greater investment to improve the scalability and consistency of manufacturing, EV-based medicine is poised to shape ...

All living organisms encode the amino acid sequences of proteins as nucleotide sequences (genetic information) in their ...